LA JOLLA, CA—Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation
LA JOLLA—It’s not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started
"Everyone is encouraged to apply for this award because it's such a good opportunity, but you are told not to get your hopes up."
LJI Postdoctoral Fellow Greet Verstichel on how T cells learn their "fate"
A Q&A with an eagle-eyed histopathologist.